A $600+Mn worth global pharmaceutical company based in South Korea approached Freyr for submission of DMF (Drug Master Files) for Ursodiol USP to HC (Health Canada). One of the key challenges faced by Freyr during the project was eCTD identifier requirement and submission roadmap. Freyr surpassed all the challenges and successfully completed the project.
How Freyr carried out the entire project? Read the case.